Sarcosine as a potential prostate cancer biomarker and therapeutic target.
作者信息
Baum Caitlin E, Price Douglas K, Figg William D
机构信息
Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
出版信息
Cancer Biol Ther. 2010 Mar 1;9(5):341-2. doi: 10.4161/cbt.9.5.11310. Epub 2010 Mar 26.
Abstract
摘要
相似文献
1
Sarcosine as a potential prostate cancer biomarker and therapeutic target.肌氨酸作为一种潜在的前列腺癌生物标志物和治疗靶点。
Cancer Biol Ther. 2010 Mar 1;9(5):341-2. doi: 10.4161/cbt.9.5.11310. Epub 2010 Mar 26.
2
GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.基于 GC/MS 的代谢组学方法，通过微波辅助衍生化验证尿肌氨酸和人前列腺癌的靶生物标志物的作用。
Anal Bioanal Chem. 2011 Aug;401(2):635-46. doi: 10.1007/s00216-011-5098-9. Epub 2011 May 29.
3
Is sarcosine a biomarker for prostate cancer?肌氨酸是否是前列腺癌的生物标志物？
J Sep Sci. 2011 Dec;34(24):3619-21. doi: 10.1002/jssc.201100572. Epub 2011 Oct 19.
4
Sarcosine as a potential prostate cancer biomarker--a review.肌氨酸作为一种潜在的前列腺癌生物标志物——综述。
Int J Mol Sci. 2013 Jul 4;14(7):13893-908. doi: 10.3390/ijms140713893.
5
Promising marker found for deadly prostate cancer.发现有望用于致命前列腺癌的标志物。
JAMA. 2009 Mar 11;301(10):1008. doi: 10.1001/jama.2009.299.
6
7
Sarcosine Prostate Cancer Biomarker Detection by Controlling Oxygen in NiO Membrane on Vertical Silicon Nanowires in Electrolyte-Insulator-Nanowire Structure.基于电解质-绝缘体-纳米线结构中 NiO 膜内氧的控制，利用垂直硅纳米线检测肌氨酸前列腺癌生物标志物。
Anal Chem. 2020 Jun 16;92(12):8064-8071. doi: 10.1021/acs.analchem.9b04745. Epub 2020 May 28.
8
The Urinary Sarcosine/Creatinine Ratio is a Potential Diagnostic and Prognostic Marker in Prostate Cancer.尿肌氨酸/肌酐比值是前列腺癌潜在的诊断和预后标志物。
Med Sci Monit. 2018 May 9;24:3034-3041. doi: 10.12659/MSM.909949.
9
Advances in biomarkers for the early diagnosis of prostate cancer.前列腺癌早期诊断生物标志物的进展
Chin J Cancer. 2010 Feb;29(2):229-33. doi: 10.5732/cjc.009.10274.
10
A Rapid Method for the Detection of Sarcosine Using SPIONs/Au/CS/SOX/NPs for Prostate Cancer Sensing.基于 SPIONs/Au/CS/SOX/NPs 的用于前列腺癌传感的肌氨酸快速检测方法。
Int J Mol Sci. 2018 Nov 22;19(12):3722. doi: 10.3390/ijms19123722.
引用本文的文献
1
Proteomic Analysis of the Low Molecular Mass Fraction of Newly Diagnosed and Recurrent Glioblastoma CUSA Fluid: A Pilot Investigation of the Peptidomic Profile.新诊断和复发性胶质母细胞瘤CUSA液低分子质量组分的蛋白质组学分析：肽组学特征的初步研究
Int J Mol Sci. 2025 Jun 24;26(13):6055. doi: 10.3390/ijms26136055.
2
SNAT2 is responsible for hyperosmotic induced sarcosine and glycine uptake in human prostate PC-3 cells.SNAT2 负责人前列腺 PC-3 细胞中海盐诱导的肌氨酸和甘氨酸摄取。
Pflugers Arch. 2022 Dec;474(12):1249-1262. doi: 10.1007/s00424-022-02752-1. Epub 2022 Sep 29.
3
Diagnostic and therapeutic biomarkers in colorectal cancer: a review.结直肠癌的诊断和治疗生物标志物：综述
Am J Cancer Res. 2022 Feb 15;12(2):661-680. eCollection 2022.
4
The Role of Sarcosine, Uracil, and Kynurenic Acid Metabolism in Urine for Diagnosis and Progression Monitoring of Prostate Cancer.肌氨酸、尿嘧啶和犬尿喹啉酸代谢产物在尿液中对前列腺癌诊断及病情进展监测的作用
Metabolites. 2017 Feb 23;7(1):9. doi: 10.3390/metabo7010009.
5
Global Prioritization of Disease Candidate Metabolites Based on a Multi-omics Composite Network.基于多组学复合网络的疾病候选代谢物全球优先级排序
Sci Rep. 2015 Nov 24;5:17201. doi: 10.1038/srep17201.
6
Expression of sarcosine metabolism-related proteins in estrogen receptor negative breast cancer according to the androgen receptor and HER-2 status.根据雄激素受体和HER-2状态，雌激素受体阴性乳腺癌中肌氨酸代谢相关蛋白的表达情况
Int J Clin Exp Pathol. 2015 Jul 1;8(7):7967-77. eCollection 2015.
7
Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.侵袭性小叶癌中肌氨酸代谢相关蛋白的表达：与浸润性导管癌的比较。
Yonsei Med J. 2015 May;56(3):598-607. doi: 10.3349/ymj.2015.56.3.598.
8
Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.根据乳腺癌转移部位的肌氨酸代谢相关蛋白表达情况
Int J Clin Exp Pathol. 2014 Oct 15;7(11):7824-33. eCollection 2014.
9
Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer.根据乳腺癌分子亚型，肌氨酸代谢相关蛋白表达差异的意义。
J Transl Med. 2014 May 28;12:149. doi: 10.1186/1479-5876-12-149.
10
Urine markers and prostate cancer.尿液标志物与前列腺癌。
Cent European J Urol. 2011;64(1):9-14. doi: 10.5173/ceju.2011.01.art2. Epub 2011 Mar 18.
本文引用的文献
1
New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.前列腺癌预后与管理的新型分子生物标志物——后前列腺特异性抗原（PSA）时代
Anticancer Res. 2009 Aug;29(8):3289-98.
2
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.代谢组学图谱揭示了肌氨酸在前列腺癌进展中的潜在作用。
Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762.
3
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.前列腺特异性抗原与前列腺癌：预测、检测及监测
Nat Rev Cancer. 2008 Apr;8(4):268-78. doi: 10.1038/nrc2351.
4
Prostate cancer imaging.前列腺癌成像。
Acta Radiol. 2008 Feb;49(1):107-20. doi: 10.1080/02841850701545821.
5
Contrast-enhanced ultrasound imaging of prostate cancer.前列腺癌的超声造影成像
Rev Urol. 2006;8 Suppl 1(Suppl 1):S29-37.
6
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.前列腺癌中TMPRSS2与ETS转录因子基因的反复融合
Science. 2005 Oct 28;310(5748):644-8. doi: 10.1126/science.1117679.
7
The polycomb group protein EZH2 is involved in progression of prostate cancer.多梳蛋白家族成员EZH2参与前列腺癌的进展。
Nature. 2002 Oct 10;419(6907):624-9. doi: 10.1038/nature01075.
Zotero 插件